TEIJIN REGENET Trademark

Trademark Overview


On Tuesday, May 30, 2023, a trademark application was filed for TEIJIN REGENET with the United States Patent and Trademark Office. The USPTO has given the TEIJIN REGENET trademark a serial number of 98018285. The federal status of this trademark filing is FIRST EXTENSION - GRANTED as of Tuesday, May 14, 2024. This trademark is owned by Teijin Kabushiki Kaisha (Teijin Limited). The TEIJIN REGENET trademark is filed in the Treatment & Processing of Materials Services, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Custom manufacture of pharmaceuticals; custom manufacture of cells; custom manufacture of biological tissue cultures; custom manufacture of cell culture medium; custom manufacture of medical apparatus; custom production of structures made of cells; custom processing of cells; consultancy relating to the manufacture of cells; providing information relating to the manufacture of cells; processing of cells used for cell therapy medicine

Pharmaceutical consultancy; provision of medical information; advisory, consultancy and information services relating to medical care and regenerative medicine; human tissue bank services; cultured cell bank services for medical transplantation; separation, collection and preservation of blood components for medical purpose

Cell culture services for others for scientific and medical research purposes; testing, inspection, research and development of cells and tissue cultures for scientific and medical research purposes; advice, consultancy and providing information relating to testing, inspection, research or development of cells and tissue culture for scientific and medical research purposes; consultancy relating to cell culture and tissue culture for medical research purposes; culture and separation of cells and biological tissue for medical research purposes; consultancy and providing information relating to testing, inspection and research of pharmaceuticals; research and product development of cells; blood analysis services for scientific research purposes; scientific services relating to the isolation and cultivation of human tissues and cells; stem cell research; technological research in the fields of stem cells and tissue culturing; scientific research and development; consultancy and advising r...
teijin regenet

General Information


Serial Number98018285
Word MarkTEIJIN REGENET
Filing DateTuesday, May 30, 2023
Status730 - FIRST EXTENSION - GRANTED
Status DateTuesday, May 14, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 17, 2023

Trademark Statements


Goods and ServicesCustom manufacture of pharmaceuticals; custom manufacture of cells; custom manufacture of biological tissue cultures; custom manufacture of cell culture medium; custom manufacture of medical apparatus; custom production of structures made of cells; custom processing of cells; consultancy relating to the manufacture of cells; providing information relating to the manufacture of cells; processing of cells used for cell therapy medicine
Goods and ServicesPharmaceutical consultancy; provision of medical information; advisory, consultancy and information services relating to medical care and regenerative medicine; human tissue bank services; cultured cell bank services for medical transplantation; separation, collection and preservation of blood components for medical purpose
Goods and ServicesCell culture services for others for scientific and medical research purposes; testing, inspection, research and development of cells and tissue cultures for scientific and medical research purposes; advice, consultancy and providing information relating to testing, inspection, research or development of cells and tissue culture for scientific and medical research purposes; consultancy relating to cell culture and tissue culture for medical research purposes; culture and separation of cells and biological tissue for medical research purposes; consultancy and providing information relating to testing, inspection and research of pharmaceuticals; research and product development of cells; blood analysis services for scientific research purposes; scientific services relating to the isolation and cultivation of human tissues and cells; stem cell research; technological research in the fields of stem cells and tissue culturing; scientific research and development; consultancy and advising relating to culturing of cells

Classification Information


International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code6 - Active
Class Status DateThursday, June 29, 2023
Primary Code040
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, June 29, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, June 29, 2023
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameTeijin Kabushiki Kaisha (Teijin Limited)
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressOsaka, Tokyo 530-0005
JP

Party NameTeijin Kabushiki Kaisha (Teijin Limited)
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressOsaka, Tokyo 530-0005
JP

Trademark Events


Event DateEvent Description
Friday, June 2, 2023NEW APPLICATION ENTERED
Monday, June 5, 2023TEAS VOLUNTARY AMENDMENT RECEIVED
Thursday, June 29, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, August 28, 2023ASSIGNED TO EXAMINER
Friday, September 8, 2023EXAMINERS AMENDMENT -WRITTEN
Friday, September 8, 2023EXAMINERS AMENDMENT E-MAILED
Friday, September 8, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, September 8, 2023EXAMINER'S AMENDMENT ENTERED
Friday, September 8, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 27, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 17, 2023PUBLISHED FOR OPPOSITION
Tuesday, October 17, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 12, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 14, 2024SOU EXTENSION 1 FILED
Tuesday, May 14, 2024SOU EXTENSION 1 GRANTED
Tuesday, May 14, 2024SOU TEAS EXTENSION RECEIVED